Androgen regulation of ETS gene fusion transcripts in prostate cancer

Delila Gasi1, Jan Trapman

  • 1Department of Pathology, Josephine Nefkens Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands. d.gasi@erasmusmc.cl

Insights

TMPRSS2-ERG gene fusions are common in prostate cancer. This study uses quantitative polymerase chain reaction (Q-PCR) to detect these fusions and investigate their androgen regulation, aiding in understanding their role in cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • TMPRSS2-ERG gene fusion is the most frequent genetic alteration in prostate cancer, occurring in 40-70% of cases.
  • Other ETS transcription factor genes (ETV1, ETV4, ETV5) are also involved in gene fusions with androgen-regulated partners.
  • The biological and molecular effects of ETS gene fusions in prostate cancer remain largely unknown.

Purpose of the Study:

  • To detect and study the incidence and properties of ETS gene fusion transcripts in prostate cancer.
  • To investigate the androgen regulation of TMPRSS2 expression in prostate cancer cells.
  • To identify novel ETS fusion partners using advanced molecular techniques.

Main Methods:

  • Quantitative polymerase chain reaction (Q-PCR) for detection and quantification of fusion transcripts.
  • Culturing LNCaP prostate cancer cells with and without synthetic androgen R1881 to measure TMPRSS2 androgen regulation.
  • Combining Q-PCR with 5' RLM-RACE and sequencing for novel fusion partner identification.

Main Results:

  • Focus on the expression of TMPRSS2-ERG transcripts in clinical prostate samples.
  • Measurement of androgen regulation of TMPRSS2 in LNCaP cells.
  • Methodology established for identifying novel ETS fusion partners.

Conclusions:

  • Q-PCR is a valuable tool for studying ETS gene fusions in prostate cancer.
  • Understanding androgen regulation of fusion genes is crucial for prostate cancer research.
  • Further research is needed to elucidate the biological significance of ETS gene fusions.